Summary
The disposition of monodesethylamodiaquine was studied in four healthy subjects after a single oral dose of 10 mg/kg amodiaquine base.
Amodiaquine was not found in any sample, but the major metabolite monodesethylamodiaquine was detected and was assumed to be the sole derivative that contributed significantly to antimalarial activity in the blood. The best fit for the decay of the metabolite was obtained with a three-compartment model. The half-lives of the first two phases were 3.2 to 11.4 h for t1/2α1 and 22.7 to 50.3 h for t1/2α2 in plasma. The half-life of the terminal phase ( t1/2β) was between 9 and 18.2 days. The concentration in whole blood was 4- to 6-times higher than in plasma.
Three schedules (alternate days, weekly, daily) of the conventional prophylactic dose of 10 mg/kg per week were compared in six other healthy subjects. There were significant differences in the plasma monodesethylamodiaquine levels between the three schedules.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Deloron P, Le Bras J, Ramanamirija JA, Coulanges P (1985)Plasmodium falciparum in Madagascar: In vivo and in vitro sensitivity to seven drugs. Ann Trop Med Parasitol 79: 357–363
Spencer HC, Oloo AJ, Watkins WW, Sixsmith DG, Churchill FC, Koech DK (1984) Amodiaquine more effective than chloroquine againstPlasmodium falciparum malaria on Kenya coast. Lancet 1: 956–957
Watkins WM, Spencer HC, Karinki DM, Sixsmith DG, Boriga DA, Kipingor T (1984) Effectiveness of amodiaquine as treatment for chloroquine-resistantPlasmodium falciparum infections in Kenya. Lancet 1: 357
Pussard E, Verdier F, Blayo MC, Pocidalo JJ (1985) Biotransformation de l'amodiaquine et prophylaxie du paludisme àPlasmodium falciparum. C R Acad Sci Paris 301 [III]: 383–385
Churchill FC, Patchen LC, Campbell CC, Schwartz IK, Nguyen-Dinh P, Dickinson CM (1985) Amodiaquine as a prodrug: Importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. Life Sci 36: 53–62
Salako LA, Idowu OR (1985) Failure to detect amodiaquine in the blood after oral administration. Br J Clin Pharmacol 20: 307–311
Trenholme GM, Williams RL, Patterson EC, Frischer H, Carson PE, Rieckmann KH (1974) A method for the determination of amodiaquine WHO Bull 51: 431–434
Winstanley P, Edwards G, Orme M, Breckenridge A (1987) The disposition of amodiaquine in man after oral administration. Br J Clin Pharmacol 23: 1–7
Mihaly GW, Nicholl DD (1985) High-performance liquid chromatography analysis of amodiaquine in human plasma. J Chromatogr 337: 166–171
White NJ, Looareesuwan S, Edwards G, Phillips RE, Karbwang J, Nicholl DD, Bunch C, Warrell DA (1987) Pharmacokinetics of intravenous amodiaquine. Br J Clin Pharmacol 23: 127–135
Hatton CSR, Peto TEA, Bunch C, Pasvol O, Russel SJ, Singer CRJ, Edwards C, Winstanley P (1986) Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet 2: 411–414
Rhodes EGH, Ball J, Franklin IM (1986) Amodiaquine induced agranulocytosis: Inhibition of colony growth in bone marrow by antimalarial agents. Br Med J 292: 717–718
Neftel KA, Woodtly W, Schmid M, Frick P, Fehr J (1986) Amodiaquine induced agranulocytosis and liver damage. Br Med J 292: 721–723
Larrey D, Castot A, Pessayre D, Merigot P, Machayekhy JP, Feldmann G, Lenoir A, Rueff B, Benhamou JP (1986) Amodiaquine-induced hepatitis: A report of seven cases. Ann Intern Med 104: 801–803
Pussard E, Verdier F, Blayo MC (1986) Simultaneous determination of chloroquine, amodiaquine and their metabolites in human plasma, red blood cells, whole blood and urine by column liquid chromatography. J Chromatogr 374: 111–118
Schwartz D (1963) Méthodes statistiques à l'usage des médecins et des biologistes. Editions Médicales Flammarion, Paris
Snedecor WG, Cochran WG (1967) Statistical methods. Iowa State University Press, Ames, Iowa
Le Bras J, Andrieu B, Hatin I, Savel J, Coulaud JP (1984)P.falciparum: interprétation du semi-microtest de chimiosensibilité in vitro par incorporation de3H-hypoxanthine. Pathol Biol (Paris) 32: 463–466
Churchill FC, Mount DL, Patchen LC (1986) Isolation, characterization and standardization of a major metabolite of amodiaquine by chromatographic and spectroscopic methods. J Chromatogr 377: 307–318
Le Brad J, Coulaud JP, Modai J, Vildé JL, Lapresle C, Dunand P, Penalba C, Cuisinier P, Bouree P, Méchali D, Roue R (1985) Chimiosensibilité dans 100 cas de paludisme d'importation observés en France entre Juin 1983 et Mai 1985. Bull Soc Fr Parasitol 1: 9–12
Frisk-Holmberg M, Bergqvist Y, Termond E, Domeij-Nyberg B (1984) The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects. Eur J Clin Pharmacol 26: 521–530
Verdier F, Clavier F, Deloron P, Blayo MC (1984) Distribution de la chloroquine et de la déséthylchloroquine dans le sang, le plasma et les érythrocytes de sujets sains et paludéens. Dosage en HPLC. Pathol Biol (Paris) 32: 359–361
Verdier F, Le Bras J, Clavier F, Hatin I (1984) Blood levels and in vitro activity of desethylchloroquine againstPlasmodium falciparum. Lancet 1: 1186–1187
Berliner RW, Earle DP, Taggart JV, Zubrod CG, Welch WJ, Conan NJ, Bauman E, Scudder ST, Shannon JA (1948) Studies on the chemotherapy of the human malarias. VI. The physiological disposition, antimalarial activity, and toxicity of several derivatives of 4-aminoquinoline. J Clin Invest 27: 98–106
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pussard, E., Verdier, F., Faurisson, F. et al. Disposition of monodesethylamodiaquine after a single oral dose of amodiaquine and three regimens for prophylaxis againstPlasmodium falciparum malaria. Eur J Clin Pharmacol 33, 409–414 (1987). https://doi.org/10.1007/BF00637639
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00637639